Stephens Inc Vertex Pharmaceuticals Inc Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Stephens Inc holds 3,548 shares of VRTX stock, worth $1.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,548

Previous 3,708 4.31%

Holding current value

$1.78 Million

Previous $1.74 Million 5.06%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$460.0 - $505.78 $73,600 - $80,924	-160 Reduced 4.31%	3,548 $1.65 Million
Q2 2024 Aug 06, 2024	SELL	$392.81 - $485.53 $141,411 - $174,790	-360 Reduced 8.85%	3,708 $1.74 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $17,530 - $19,181	43 Added 1.07%	4,068 $1.7 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $109,760 - $131,417	-320 Reduced 7.36%	4,025 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $19,952 - $21,385	-59 Reduced 1.34%	4,345 $1.51 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $94,326 - $105,573	-300 Reduced 6.38%	4,404 $1.55 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $77,605 - $88,529	274 Added 6.19%	4,704 $1.48 Million
Q4 2022 Jan 25, 2023	SELL	$285.76 - $321.48 $78,298 - $88,085	-274 Reduced 5.82%	4,430 $1.28 Million
Q3 2022 Nov 02, 2022	SELL	$273.83 - $305.53 $480,571 - $536,205	-1,755 Reduced 27.17%	4,704 $1.36 Million
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $234,960 - $292,550	-1,000 Reduced 13.41%	6,459 $1.82 Million
Q1 2022 May 04, 2022	SELL	$221.42 - $260.97 $895,422 - $1.06 Million	-4,044 Reduced 35.16%	7,459 $1.95 Million
Q4 2021 Mar 07, 2022	SELL	$177.01 - $223.45 $441,816 - $557,731	-2,496 Reduced 17.83%	11,503 $2.53 Million
Q3 2021 Oct 27, 2021	SELL	$181.39 - $202.99 $650,827 - $728,328	-3,588 Reduced 20.4%	13,999 $2.54 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $13,874 - $16,361	-74 Reduced 0.42%	17,587 $3.55 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $426,047 - $496,615	2,058 Added 13.19%	17,661 $3.8 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $565,137 - $753,725	2,730 Added 21.21%	15,603 $3.69 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $495,705 - $587,710	1,939 Added 17.73%	12,873 $3.5 Million
Q2 2020 Aug 24, 2020	BUY	$225.48 - $295.8 $555,808 - $729,147	2,465 Added 29.11%	10,934 $3.17 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $42,151 - $52,287	-211 Reduced 2.43%	8,469 $2.02 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $330,085 - $443,341	-1,980 Reduced 18.57%	8,680 $1.9 Million
Q3 2019 Oct 18, 2019	SELL	$166.23 - $187.09 $51,365 - $57,810	-309 Reduced 2.82%	10,660 $1.81 Million
Q2 2019 Aug 01, 2019	SELL	$164.61 - $190.37 $61,070 - $70,627	-371 Reduced 3.27%	10,969 $2.01 Million
Q1 2019 May 03, 2019	SELL	$163.73 - $194.7 $87,268 - $103,775	-533 Reduced 4.49%	11,340 $2.09 Million
Q4 2018 Feb 11, 2019	BUY	$151.91 - $192.21 $30,382 - $38,442	200 Added 1.71%	11,873 $1.97 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $1.96 Million - $2.25 Million	11,673 New	11,673 $2.25 Million
Q3 2017 Nov 08, 2017	SELL	$148.13 - $162.24 $1.97 Million - $2.16 Million	-13,315 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	13,315	13,315 $1.72 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account